BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single site involved in the TRANQUILITY II Phase 3 trial under 21 C.F.R.20.64(d)(3). The FDA’s designation of “Voluntary Action Indicated” (VAI) signals that while minor issues may have been identified, no regulatory action is required, further […]
Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
Telomir Pharmaceuticals (NASDAQ: TELO) has achieved a major scientific breakthrough by stabilizing Silver(II) (Ag²⁺) using its proprietary compound, Telomir-1. This advancement overcomes a key challenge in silver-based medicine, unlocking new possibilities for antimicrobial treatments, wound care, and infection-resistant medical coatings. Silver(II) offers superior antibacterial action, faster wound healing, and immune-modulating properties compared to traditional Silver(I) […]
Inspira Technologies Reports Breakthrough in Infection Prevention with Bio-Electronic Patch
Inspira Technologies (NASDAQ: IINN) has reported promising pre-clinical results for its bio-electronic anti-bacterial IV dressing technology, developed in collaboration with Ennocure MedTech Ltd. The innovative solution aims to combat bloodstream infections, a critical issue affecting an estimated 250,000 patients worldwide each year due to contaminated intravenous (IV) lines. In ex-vivo testing using a porcine skin […]
Biodexa’s eRapa Granted FDA Fast Track Designation for Familial Adenomatous Polyposis
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) has secured Fast Track designation from the U.S. Food and Drug Administration (FDA) for its investigational drug eRapa, a proprietary encapsulated form of rapamycin, for the treatment of familial adenomatous polyposis (FAP). This designation is designed to accelerate the development and review process for drugs that address serious conditions with […]
Conduit and Sarborg Advance to Phase II of AI-Driven Drug Development
Conduit Pharmaceuticals (NASDAQ: CDT) announced the successful completion of Phase I in its AI-driven drug development collaboration with Sarborg Limited. With all milestones achieved, the partnership is now transitioning to Phase II, which will focus on developing personalized software dashboards to improve operational efficiency and decision-making. Phase I, initiated in December 2024, laid the groundwork […]
Inspira Technologies Enhances AI-Powered HYLA Blood Sensor with Advanced Oxygenation Indicator
Inspira Technologies (Nasdaq: IINN), a leader in life-support innovation, has announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA™ blood sensor. This enhancement is designed to enable rapid, continuous detection of oxygen-related conditions without requiring intermittent blood draws, marking a significant advancement in critical care monitoring. The newly integrated oxygenation indicator facilitates […]
KULR and Scripps Research Pioneer Affordable Pyrolytic Carbon Electrodes
KULR Technology Group, Inc. (NYSE: KULR) has partnered with Scripps Research Institute’s Baran Lab to create an innovative pyrolytic carbon (PC) electrode material. This groundbreaking development offers a cost-effective, scalable, and durable alternative to traditional electrodes like reticulated vitreous carbon (RVC) and glassy carbon (GC). Produced using a proprietary chemical vapor deposition (CVD) process, the […]
MicroCloud Hologram Advances Quantum Technology with High-Fidelity Qubit Control
MicroCloud Hologram (HOLO) has unveiled a groundbreaking advancement in quantum technology: a fast adiabatic driving protocol for achieving coherent control of two heavy hole spin qubits in a double quantum dot (QD) system. This innovative approach surpasses traditional quantum control methods, offering significant improvements in fidelity and stability for quantum information processing. A Leap Beyond […]
MySize Reports Strong Revenue Growth and Expands Global Footprint
MySize, Inc. (NASDAQ: MYSZ), a global leader in AI-powered sizing solutions and omnichannel e-commerce platforms, has released its annual shareholder update, showcasing a year of impressive growth, strategic advancements, and promising future opportunities. Delivering on Revenue and Efficiency MySize projects closing 2024 with $8.5 million in revenue, marking a 23% year-over-year increase. The company attributes […]
European Markets Open Higher Amid Holiday Week, Novo Nordisk Rebounds
Markets Begin Festive Week on a Positive Note as Novo Nordisk Recovers From Friday’s Plunge European markets started the week on a positive trajectory, with the pan-European Stoxx 600 index gaining 0.4% in early Monday trading. Most sectors posted gains as investors settled into a shortened trading week ahead of the Christmas holiday. Positive Momentum […]